1-[2-(2,4 dimethylphenylsulfanyl)-phenyl]piperazine as a compound with combined serotonin reuptake, 5-HT3 and 5-HT1a activity for the treatment of cognitive impairment | Patent Number 09227946
US 09227946 B2Filled DateApr 1, 2014
Priority DateJun 16, 2006
Publication DateSep 4, 2014
Expiration DateJun 15, 2026
Inventor/ApplicantsHeidi Lopez de Diego
Rene Holm
Andre Faldt
Rene Holm
Andre Faldt
ExaminesPOLANSKY, GREGG
Art Unit1621
Technology Center1600
Assignments
Law Firm
You must be logged in to view
LoginAttorneys
Subscription-Only
View Concierge ProgramEmpower your practice with Patexia Publication Prosecution IP Module.
Get access to our exclusive rankings and unlock powerful data.
Looking for a Publication Attorney?
Get in touch with our team or create your account to start exploring a
network of over 120K attorneys.